The effect of empagliflozin on non-alcoholic fatty liver disease-related parameters in patients with type 2 diabetes mellitus: a randomized controlled trial
Registered retrospectively in the Iranian Registry of Clinical Trials (IRCT20210811052150N1) on April 16,2023 Access at https://irct.behdasht.gov.ir/search/result?query=IRCT20210811052150N1 .
Authors
- Azam Erfanifar
- Saeid Kalbasi (ORCID: https://orcid.org/0009-0009-5921-3709)
- Fatemeh Shojaei (ORCID: https://orcid.org/0000-0002-7365-4422)
- Latif Gachkar (ORCID: https://orcid.org/0000-0002-5314-5022)
- Shahriar Nikpour
Institutions
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- BMC Endocrine Disorders
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1186/s12902-025-01882-8
- Citations
- 11
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 14.90